Oncology

AstraZeneca's 40+ years of cancer drug development globally has improved survival rates.
With a commitment to advancing oncology science, our goal is to eliminate cancer deaths through discovery and accessibility.

Lung
Cancer

GI
Cancer

Prostate
Cancer

Breast
Cancer

Ovarian
Cancer

Pancreatic
Cancer

Endometrial
Cancer

Tumour
Agnostic

Ovarian cancer

We are augmenting our commitment to ovarian cancer. Read more on our approach to using ground-breaking science to further our understanding of the many biomarkers involved in ovarian cancer and how new therapies can be used to target these and improve outcomes.

 

 

Lynparza - Ovarian cancer

 

Click here

 

 

 

 

Back to top